| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Austria | 5 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Measurement | |
| #5 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Enzymes | |
| #5 | Analysing materials | |
| #6 | Peptides | |
| #7 | Animal care | |
| #8 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Schuster Manfred | 7 |
| #2 | Loibner Hans | 7 |
| #3 | Janzek-Hawlat Evelyne | 3 |
| #4 | Peball Bernhard | 2 |
| #5 | Manfred Schuster | 1 |
| #6 | Wolf Dominik | 1 |
| #7 | Stefan Stranner | 1 |
| #8 | Evelyne Janzek-Hawlat | 1 |
| #9 | Bernhard Peball | 1 |
| #10 | Robert Weik | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AT508109A1 | Method for determining the cbl-b expression | |
| AT506632A1 | Treatment of tumor diseases | |
| EP2108695A1 | Ace2 polypeptide | |
| EP2077119A1 | Treatment of fibrosis and liver diseases | |
| AT506258A1 | Treatment of inflammatory diseases | |
| AT505262A1 | New recombinant angiotensin I converting enzyme 2 polypeptide comprising specific amount of glycosylated and sugar portion, useful for enzyme substitution therapy for treating acute respiratory distress syndrome or acute lung injury | |
| AT504443A1 | Method for determining the activity of ace2 |